Zolfo Cooper advises Agilitas on another transformational European buy-out
Zolfo Cooper, the leading independent provider of advisory and restructuring services, has completed a new debt raising mandate on behalf of Agilitas, a pan-European mid-market private equity firm, to finance the acquisition of Financiere Ionisos SAS (Ionisos), one of Europe’s major providers of cold sterilisation services, from Naxicap Partners.
Ionisos leads the provision of cold sterilisation services in France and Spain. It is the only company licensed in France to offer all three cold sterilisation technologies: gamma irradiation, beta irradiation and Ethylene Oxide. Its services are used by multinational and local companies for the sterilisation of single-use products. These include medical devices, pharmaceutical, food and pharma packaging and cosmetics products.
The debt advisory team ran a competitive debt raising process to deliver an attractive financing package comprising a unitranche facility provided by Intermediate Capital Group and a revolving credit facility provided by BNP Paribas. The unitranche includes a committed add-on facility which, alongside significant future capital from Agilitas, will allow Ionisos’ ambitious management team to grow the business in France by expanding its treatment capacity and enlarging the service offering, and to pursue international expansion to transform Ionisos into a truly pan-European business.
Tom Cox, director in Zolfo Cooper’s debt advisory team, said: “We are delighted to have taken a lead role advising Agilitas on another transformational buy-out opportunity. Ionisos is an exciting platform with real growth potential, particularly through its pan-European growth strategy.”
Zolfo Cooper’s debt advisory team, led by Jacco Brouwer, brings together significant loan and capital markets expertise, combining extensive experience of international debt markets and delivering bespoke debt solutions to borrowers, lenders and sponsors across the business life cycle.